Blackrock Health Sciences Etf Current Valuation
| BME Etf | USD 39.07 0.18 0.46% |
Valuation analysis of BlackRock Health Sciences helps investors to measure BlackRock Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Fundamental drivers impacting BlackRock Health's valuation include:
Price Book 0.8659 | Enterprise Value 548.3 M | Price Sales 66.7777 | Trailing PE 9.9873 | Enterprise Value Revenue 9.6932 |
Fairly Valued
Today
Please note that BlackRock Health's price fluctuation is very steady at this time. Calculation of the real value of BlackRock Health Sciences is based on 3 months time horizon. Increasing BlackRock Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BlackRock etf is determined by what a typical buyer is willing to pay for full or partial control of BlackRock Health Sciences. Since BlackRock Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BlackRock Etf. However, BlackRock Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.07 | Real 38.96 | Hype 39.08 |
The real value of BlackRock Etf, also known as its intrinsic value, is the underlying worth of BlackRock Health Sciences ETF, which is reflected in its stock price. It is based on BlackRock Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BlackRock Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BlackRock Health Sciences helps investors to forecast how BlackRock etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BlackRock Health more accurately as focusing exclusively on BlackRock Health's fundamentals will not take into account other important factors: BlackRock Health Sciences ETF Current Valuation Analysis
BlackRock Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BlackRock Health Current Valuation | 548.33 M |
Most of BlackRock Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BlackRock Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BlackRock Health Sciences has a Current Valuation of 548.33 M. This is much higher than that of the Capital Markets family and significantly higher than that of the Financials category. The current valuation for all United States etfs is notably lower than that of the firm.
BlackRock Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BlackRock Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of BlackRock Health could also be used in its relative valuation, which is a method of valuing BlackRock Health by comparing valuation metrics of similar companies.BlackRock Health is currently under evaluation in current valuation as compared to similar ETFs.
BlackRock Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BlackRock Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BlackRock Health's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
BlackRock Fundamentals
| Return On Equity | 0.0901 | ||||
| Return On Asset | 0.0017 | ||||
| Profit Margin | 6.84 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 548.33 M | ||||
| Shares Outstanding | 13.6 M | ||||
| Shares Owned By Institutions | 23.03 % | ||||
| Number Of Shares Shorted | 15.05 K | ||||
| Price To Earning | 6.69 X | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 66.78 X | ||||
| Revenue | 8.19 M | ||||
| Gross Profit | 7.99 M | ||||
| EBITDA | 20.02 M | ||||
| Net Income | 20.02 M | ||||
| Cash And Equivalents | 16.68 K | ||||
| Total Debt | 60.69 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 0.36 X | ||||
| Book Value Per Share | 44.20 X | ||||
| Cash Flow From Operations | 32.02 M | ||||
| Short Ratio | 0.19 X | ||||
| Earnings Per Share | 3.93 X | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 533.62 M | ||||
| Total Asset | 596.1 M | ||||
| Retained Earnings | 170.52 M | ||||
| Annual Yield | 0.08 % | ||||
| Five Year Return | 5.86 % | ||||
| Net Asset | 596.1 M | ||||
| Last Dividend Paid | 2.56 |
About BlackRock Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BlackRock Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BlackRock Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BlackRock Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.